Bladder Cancer Health Center

Font Size

Bladder and Other Urothelial Cancers Screening (PDQ®) - Summary of Evidence

Note: Separate PDQ summaries on Bladder Cancer Treatment and Levels of Evidence for Cancer Screening and Prevention Studies are also available.

Benefits

There is inadequate evidence to determine whether screening for bladder and other urothelial cancers would have any impact on mortality.

Description of the Evidence

STUDY DESIGN: There are no studies that directly address this question.
INTERNAL VALIDITY: N/A.
CONSISTENCY: N/A.
MAGNITUDE OF EFFECTS ON HEALTH OUTCOMES: N/A.
EXTERNAL VALIDITY: N/A.

Harms

Based on fair evidence, screening for bladder and other urothelial cancers would result in unnecessary diagnostic procedures with attendant morbidity.

Description of the Evidence

STUDY DESIGN: Opinions of respected authorities based on clinical experience, descriptive studies, or reports of expert committees.
INTERNAL VALIDITY: N/A.
CONSISTENCY: N/A.
MAGNITUDE OF EFFECTS ON HEALTH OUTCOMES: Good evidence for rare harms.
EXTERNAL VALIDITY: N/A.

WebMD Public Information from the National Cancer Institute

This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER

Last Updated: February 20, 2007

This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.

Some material in CancerNet™ is from copyrighted publications of the respective copyright claimants. Users of CancerNet™ are referred to the publication data appearing in the bibliographic citations, as well as to the copyright notices appearing in the original publication, all of which are hereby incorporated by reference.